NEW MARKETLINK PHARMACEUTICAL CORP

Location: Philippines

Company Classification:

NEW MARKETLINK PHARMACEUTICAL CORP is a trading company. It functions primarily as a distributor and marketer of pharmaceutical products, rather than a manufacturing factory.

Company Introduction:

NEW MARKETLINK PHARMACEUTICAL CORP (NMPC) is a leading Filipino-owned pharmaceutical company based in the Philippines. The company is actively involved in the marketing and distribution of a diverse portfolio of quality and affordable branded generic medicines and various allied healthcare products. NMPC plays a crucial role in the Philippine healthcare sector by ensuring the accessibility of essential pharmaceutical goods to the market through its established distribution channels. Its core business model focuses on connecting pharmaceutical manufacturers with healthcare providers and consumers across the country.

NEW MARKETLINK PHARMACEUTICAL CORP in the Philippines primarily distributes a wide range of pharmaceutical products and medical devices. They partner with various international pharmaceutical companies to bring their products to the Philippine market.

Their product portfolio generally covers the following therapeutic classes:

Cardiovascular System products

Central Nervous System products

Diabetes medications

Dermatology products

Gastro-intestinal Tract medications

Genito-Urinary Tract and Sex Hormones

Musculo-skeletal System products

Oncology medications

Respiratory System products

Systemic Anti-infectives

Vitamins and Minerals

They also distribute various Medical Devices and Diagnostic products.

Examples of product types they distribute include:

Analgesics

Antibiotics

Anti-inflammatory drugs

Antidiabetic agents

Antihypertensives

Cough and cold remedies

Multivitamins

Skincare preparations